VCEL Vericel
- 42.490
- +0.400+0.95%
Vericel News
Vericel Corp (VCEL) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ...
Vericel Corp Executive Sells Shares Worth Over $265k
Even Though Vericel (NASDAQ:VCEL) Has Lost US$267m Market Cap in Last 7 Days, Shareholders Are Still up 173% Over 5 Years
Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024
The Analyst Verdict: Vericel In The Eyes Of 7 Experts
CCORF Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $57
BTIG Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $55
TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $60
Buy Rating on Vericel: Expanding Market Reach With FDA-Approved MACI Arthro Platform
Vericel Says US FDA Approves SBLA for Tissue Restoring Knee Repair Treatment - Shares Up Pre-Bell
Vericel Gains FDA Approval for Arthroscopic Delivery of MACI in Knee Cartilage Treatments
Express News | Vericel Announces FDA Approval and Commercial Availability of Maci Arthro
Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), Vericel (VCEL) and Twist Bioscience (TWST)
Express News | Vericel Corp Shares Down 1.4% After Co Files for Mixed Shelf Offering
Express News | Vericel Corp Files for Mixed Shelf Offering; Size Not Disclosed- SEC Filing
MediWound and Vericel Win FDA Paediatric Label Expansion for NexoBrid
TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $55
TD Cowen Keeps Their Buy Rating on Vericel (VCEL)
Express News | Vericel Announces FDA Approval of Nexobrid for the Treatment of Pediatric Patients With Severe Thermal Burns
Analysis
Price Target
No Data
No Data
